Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against S. pneumoniae infection in mice.

about

The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation

P2860

Q57490842-8CC070D6-FCA3-4C8C-885F-47A45C7C76FA Q58596157-3054E848-63E4-4828-885E-95ECB11FBD4C

P2860

Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against S. pneumoniae infection in mice.

Item

http://www.wikidata.org/entity/Q40277871

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Utilization of cholera toxin B ...... pneumoniae infection in mice.

@en

type

Item

label

Utilization of cholera toxin B ...... pneumoniae infection in mice.

@en

prefLabel

Utilization of cholera toxin B ...... pneumoniae infection in mice.

@en

P1476

Utilization of cholera toxin B ...... pneumoniae infection in mice.

@en

P2093

Constantine Bitsaktsis

http://www.w3.org/2001/XMLSchema#string

Daniel Pinho

http://www.w3.org/2001/XMLSchema#string

Kari Wiedinger

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccines for preventing pneumococcal infection in adults

Cholera Toxin Subunit B as Adjuvant--An Accelerator in Protective Immunity and a Break in Autoimmunity

Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice

Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.

T-cell-receptor-dependent signal intensity dominantly controls CD4(+) T cell polarization In Vivo.

Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.

Interferon-γ production by neutrophils during bacterial pneumonia in mice.

Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.

P304

15-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2051013617691041

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28344805

http://www.w3.org/2001/XMLSchema#string

P921

Binghsiqrueg

P932

5349335

http://www.w3.org/2001/XMLSchema#string

Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against S. pneumoniae infection in mice.

about

P2860

P2860

Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against S. pneumoniae infection in mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932